Can Sporadic Medullary Thyroid Carcinoma Be Biochemically Predicted? Prospective Analysis of 66 Operated Patients with Elevated Serum Calcitonin Levels

[1]  H. Holzhausen,et al.  Differential diagnosis of calcitonin-secreting neuroendocrine carcinoma of the foregut by pentagastrin stimulation , 2000, Langenbeck's Archives of Surgery.

[2]  E. Baudin,et al.  Gastroenteropancreatic neuroendocrine tumor metastases to the thyroid gland: differential diagnosis with medullary thyroid carcinoma. , 1999, European journal of endocrinology.

[3]  D. Carter TNM Classification of Malignant Tumors , 1998 .

[4]  B. Conte Devolx,et al.  Latent Subclinical Medullary Thyroid Carcinoma: Diagnosis and Treatment , 1998, World Journal of Surgery.

[5]  M. Schlumberger,et al.  Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients , 1998 .

[6]  C. Bieglmayer,et al.  Routine measurement of plasma calcitonin in nodular thyroid diseases. , 1997, The Journal of clinical endocrinology and metabolism.

[7]  P. Caron,et al.  Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. The French Medullary Study Group. , 1997, The Journal of clinical endocrinology and metabolism.

[8]  M. Rieu,et al.  Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules , 1995, Clinical endocrinology.

[9]  B. Franc,et al.  C-cell hyperplasia associated with chronic lymphocytic thyroiditis: a retrospective quantitative study of 112 cases. , 1994, Human pathology.

[10]  A. Pinchera,et al.  Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma. , 1994, The Journal of clinical endocrinology and metabolism.

[11]  A. Vinik,et al.  Calcitonin immunoreactivity and hypercalcitoninemia in two patients with sporadic, nonfamilial, gastroenteropancreatic neuroendocrine tumors. , 1992, Surgery.

[12]  M. Brennan,et al.  Symptomatic C-cell hyperplasia associated with chronic lymphocytic thyroiditis. , 1991, The American journal of surgical pathology.

[13]  M. Nadji,et al.  C-cell hyperplasia in thyroid tissue adjacent to follicular cell tumors. , 1988, Human pathology.

[14]  M. Montesco,et al.  Parafollicular C-Cell Hyperplasia. Report of Three Cases in Primary Thyroid Lymphomas , 1988, Tumori.

[15]  S. Lindsay,et al.  Medullary carcinoma of the thyroid gland. , 1965, Archives of pathology.

[16]  E. Baudin,et al.  Screening for multiple endocrine neoplasia type 1 and hormonal production in apparently sporadic neuroendocrine tumors. , 1999, The Journal of clinical endocrinology and metabolism.

[17]  P. Niccoli,et al.  Results of the calcitonin stimulation test in normal volunteers compared with genetically unaffected members of MEN 2A and familial medullary thyroid carcinoma families. , 1997, Annales d'endocrinologie.

[18]  V. Livolsi C cell hyperplasia/neoplasia. , 1997, The Journal of clinical endocrinology and metabolism.

[19]  P. Niccoli,et al.  [Hypercalcitoninemia in conditions other than medullary cancers of the thyroid]. , 1996, Annales d'endocrinologie.

[20]  S. Guyétant,et al.  [Non-neoplastic hypercalcitoninemia. Pathological anatomy]. , 1996, Annales d'endocrinologie.

[21]  E. Baudin,et al.  Abnormal calcitonin basal levels and pentagastrin response in patients with chronic renal failure on maintenance hemodialysis. , 1995, European journal of endocrinology.

[22]  V. Rohmer,et al.  Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma. , 1994, The Journal of clinical endocrinology and metabolism.